Cerebrospinal Fluid Proteomics in Down Syndrome Identifies Common and Unique Pathological Changes Compared to Late‐Onset and Autosomal Dominant Alzheimer’s Disease

Shijia Bian, Laia Montoliu‐Gaya, Eric B. Dammer, Mathias Sauer, Daniel Alcolea, Kaj Blennow, Henrik Zetterberg, Juan Fortea, Erik C.B. Johnson · 2025

Read Cerebrospinal Fluid Proteomics in Down Syndrome Identifies Common and Unique Pathological Changes Compared to Late‐Onset and Autosomal Dominant Alzheimer’s Disease by Shijia Bian, Laia Montoliu‐Gaya, Eric B. Dammer, Mathias Sauer, Daniel Alcolea, Kaj Blennow, Henrik Zetterberg, Juan Fortea, Erik C.B. Johnson (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715479.txt.

Description

Shijia Bian and co-authors report a 2025 study of spinal fluid proteins in Down syndrome. Almost all people with Down syndrome develop Alzheimer disease by their seventh decade of life. The team asked whether the fluid changes in this group match those seen in other forms of the disease.

The study measured more than a thousand proteins in fluid from five groups of people. Some changes were shared across all forms of the disease, such as signs of immune activity and lost nerve contact markers. Most shared changes tracked with two proteins tied to brain plaques and tangles. The Down syndrome group also showed early rises in some defense proteins that set it apart.

Catalog record

CREATORShijia Bian, Laia Montoliu‐Gaya, Eric B. Dammer, Mathias Sauer, Daniel Alcolea, Kaj Blennow, Henrik Zetterberg, Juan Fortea, Erik C.B. Johnson
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11715479

Browse the full library · About the Tower of Babel